Product Information
ZENZEDI 30 MG TABLET is a brand (anda) product labeled by Azurity Pharmaceuticals Inc., priced at $10.4026 per EA under NDC 24338085603. Its NADAC has been published 89 times since May 12, 2021.
FDA first approved this application on Oct 25, 2011. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Azurity Pharmaceuticals Inc.NDC
24338085603
Classification
Brand (ANDA)
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA090533FDA Approved
10/25/2011
TE Code
AA
On Market Since
5/1/2014
Pharmacological Classes
Price Statistics
The NADAC for ZENZEDI 30 MG TABLET has been published 89 times since May 12, 2021, and over the history we have for it it has risen 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.4026 per EA |
|---|---|
| All-time high | $10.4633 (Apr 15, 2026) |
| All-time low | $7.0563 (Jul 21, 2021) |
| 52-week high | $10.4633 |
| 52-week low | $10.3963 |
| Median price | $7.0563 |
| Average price | $8.0773 |
| Largest weekly change | +47.3% (Feb 18, 2026) |
| Weeks tracked | 89 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZENZEDI 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZENZEDI 30 MG TABLET, manufactured by Azurity Pharmaceuticals Inc., is $10.4026 per EA (NDC 24338085603), effective Aug 19, 2026.
How has the price of ZENZEDI 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZENZEDI 30 MG TABLET has risen 46.9%. It has been tracked across 89 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for ZENZEDI 30 MG TABLET?
Since May 12, 2021, the NADAC for ZENZEDI 30 MG TABLET has ranged from a low of $7.0563 (Jul 21, 2021) to a high of $10.4633 (Apr 15, 2026), with a median of $7.0563 per EA.
Are there cheaper alternatives to ZENZEDI 30 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMPHETAMINE 30 MG TAB, is $5.5321 per EA — about 47% below ZENZEDI 30 MG TABLET.
Who manufactures ZENZEDI 30 MG TABLET?
ZENZEDI 30 MG TABLET (NDC 24338085603) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand (anda) product.